Prostate Cancer – Risk of Recurrence

Prostate Cancer – Risk of Recurrence

 

Oncotype DX® Prostate Cancer Assay

Test available from:

Oncotypeiq

The Oncotype DX Genomic Prostate Score (GPS) assay is the only genomic assay designed for men with clinically low-risk cancer to help make treatment decisions at the time of diagnosis. The assay analyzes prostate cancer gene activity to predict disease aggressiveness.
 

Article source: Oncotypeiq

Please share this page